Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
European Trade Commissioner Maros Sefcovic told lawmakers the EU expects a transitional phase of several months with the United States after Washington imposed a temporary import surcharge that may override a bilateral trade deal. U.S. officials have reassured him they still back last year’s agreement, but the temporary tariff - potentially in plac…
U.S. software equities that announced collaborations with AI startup Anthropic rose on Tuesday, leading a sector rebound after recent steep declines. Anthropic said it is building “plug-ins” with partners to assist with tasks in investment banking, wealth management and HR. The news lifted partner stocks and broader software benchmarks, reversing s…
Morgan Stanley upgraded Freshpet from equal weight to overweight and set a $90 price target, saying it now expects the company’s revenue growth to have hit a low in Q4 2025 and to accelerate through 2026. The firm raised its valuation multiple to roughly 17.5 times calendar 2027 EV/EBITDA and pointed to expanded same-day grocery delivery at Walmart…
Murray Stahl, President and Co-Portfolio Manager of RENN Fund, Inc. (RCG), purchased a total of 1,134 common shares on February 23, 2026, paying $2.87 per share for an aggregate outlay of $3,254. The transaction included both direct and indirect acquisitions through several affiliated entities. After the purchases, Stahl directly holds 149,894 shar…
Coeur Mining (CDE) is trading at $24.37 with a market cap around $15.6B despite a recently reported 4.4M oz of proven and probable gold reserves valued at roughly $22.1B at current gold. The balance sheet is clean, free cash flow is robust ($665.7M last reported), and technicals show short-term momentum. This trade idea buys that gap between reserv…
Hubbell combines stable electrical-products cash flow with a timely push into high-voltage grid infrastructure via the DMC Power deal. Fundamentals and technicals favor a measured long entry; valuation is rich but supported by high returns and free cash flow. Trade plan included with clear entry, stop and target for a long-term (180 trading days) s…
Director Ladhani Holli C. purchased 3,600 shares of Kayne Anderson Energy Infrastructure Fund, Inc. (KYN) on February 23, 2026, paying $13.89 per share for a total of $50,004. The transaction was disclosed on a Form 4 filing with the SEC. The fund reports $2.3 billion in net assets and a net asset value of $13.79 per share as of November 30, 2025; …
Wedbush increased its price target on Kiniksa Pharmaceuticals to $53 from $50 and kept an Outperform rating, citing adjustments to launch expectations for the KPL-387 program. The firm’s valuation is driven by a sum-of-parts approach using 8x revenue multiples and specific discount rates for projected U.S. sales of Arcalyst and KPL-387. Kiniksa rep…
The Department of Homeland Security has decided not to proceed with a planned Immigration and Customs Enforcement detention facility in Merrimack, New Hampshire, Governor Kelly Ayotte said following a meeting with DHS leadership. The withdrawal occurs amid a broader federal push to expand detention capacity and intensifying political, legal and pub…
A federal judge in San Francisco has denied Tesla's effort to dismiss a proposed class action accusing the automaker of favoring foreign visa holders in hiring and using that practice to reduce labor costs. The judge said the lead plaintiff provided enough factual allegations to keep most claims alive but signaled skepticism about the likelihood of…
Poland's WIG30 closed lower on Tuesday, slipping 0.59% as losses in Information Technology, Developers and Banking stocks outpaced gains. Market breadth favored decliners, while oil, Brent and gold futures each moved lower. Major zloty crosses were largely unchanged and the US Dollar Index Futures inched higher.
Denmark's main equity gauge finished the session lower after the close on Tuesday, driven by losses in Software & Computer Services, Financials and Healthcare. The OMX Copenhagen 20 fell 1.36% to a fresh three-year low, with a mix of individual gains and notable declines among large-cap names. Commodity and currency markets saw modest moves alongsi…
Iran has signalled readiness to take whatever measures are necessary to reach an agreement with the United States ahead of planned talks in Geneva, its deputy foreign minister said. Senior U.S. officials are due to meet an Iranian delegation for the negotiations amid a U.S. military buildup in the Middle East and continuing disputes over uranium en…
S&P Global Ratings upgraded Alior Bank S.A.'s long- and short-term issuer credit ratings to 'BBB-/A-3' from 'BB+/B', and affirmed its resolution counterparty ratings at 'BBB/A-2'. The upgrade reflects the bank's 2025 progress in diversifying lending toward mortgages and SME loans, sharply cutting nonperforming loans in the fourth quarter and mainta…
UBS nudged up its price target on Axsome Therapeutics to $251 from $248 while keeping a Buy rating following the company's fourth-quarter fiscal 2025 results. The stock slid after the report as investors reacted to higher projected spending to expand the sales force, even as revenue climbed 65.6% year-over-year to $638.5 million and Auvelity sales …
UBS reiterated its Buy rating on Gap, Inc. and kept a $41.00 price target, citing healthy fourth-quarter and early first-quarter sales trends that should produce a small Q4 earnings-per-share beat and support a solid fiscal 2026 guide. Valuation data indicates the shares may be trading below fair value at the current price, while option-implied and…
Mizuho has reaffirmed an Outperform rating and a $50.00 price target on Chewy Inc. after the company tapped Chris Deppe as its new chief financial officer. Deppe, elevated from vice president of finance, brings more than 15 years of experience at Amazon in fulfillment, final mile and automation. Analysts highlight the appointment as constructive ev…
Unity Software shares moved higher after a report said the company is weighing strategic options for its China operations, including a possible sale. Sources said Unity has engaged an adviser to solicit interest and may seek a valuation in excess of $1 billion, though talks are ongoing and may not produce a deal. A company representative did not im…
Micron sits at the intersection of a structural AI demand boom and acute memory supply tightness. With HBM capacity sold out, gross margins expanding, a market cap near $485B and improving fundamentals, MU looks like a buyable long for investors who want exposure to AI infrastructure without buying GPUs. This trade idea lays out an entry at $431.22…
The family of 84-year-old Nancy Guthrie is offering a reward of up to $1 million for information that leads to her recovery, a move announced in a video posted to Instagram by her daughter. Authorities and relatives continue to seek answers after a February 1 incident in which a masked man tampered with the doorbell camera at Guthrie's Tucson home …
Relatives of victims from a fatal mid-air collision and lawmakers urged the U.S. House of Representatives to move forward with the ROTOR Act, a bill that would require aircraft operators to install automatic dependent surveillance-broadcast (ADS-B) systems by the end of 2031 and direct routine military training flights to use ADS-B, while exempting…
Stifel maintained a Buy rating and a $25.00 price target for Fulcrum Therapeutics (NASDAQ: FULC) after clinical readouts showed the company’s pociredir produced meaningful increases in fetal hemoglobin (HbF) and a favorable safety profile. The shares, trading at $9.32, have delivered substantial gains over the last year, while separate valuation da…
UBS maintained a Buy rating and a $60.00 price target on MBX Biosciences, citing confidence in the company’s diversified pipeline, including a PTH program slated for Phase III and a long-acting obesity candidate advancing in early human studies. The company recently completed an at-the-market equity raise and added a new independent director, while…
UBS reduced its price target on Laureate Education Inc. to $37.50 from $39.00 while keeping a Buy rating after reviewing the company's fourth-quarter results and 2026 guidance. The bank cut its 2026 and 2027 earnings estimates, citing margin pressures tied to student intake seasonality and the ramp-up of a new campus. Laureate reported mixed fourth…
UBS increased its price objective for Keysight Technologies to $340 from $230 and maintained a Buy rating after the company reported stronger-than-expected first-quarter results and issued a lofty second-quarter revenue outlook. Management commentary and UBS analysis point to expanding AI-related demand, while valuation metrics suggest shares are t…
